Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  16 results for ""Cyclic Nucleotide Phosphodiesterases, Type 1""

Your Filters

Publication : biochemical pharmacology
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phosphodiesterase isozymes involved in regulation of HCO3- secretion in isolated mouse duodenum in vitro.

  • Authors : Hayashi M; Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8414, Japan.; Kita K

Subjects: Bicarbonates/Bicarbonates/Bicarbonates/*metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 1/Cyclic Nucleotide Phosphodiesterases, Type 1/Cyclic Nucleotide Phosphodiesterases, Type 1/*metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 3/Cyclic Nucleotide Phosphodiesterases, Type 3/Cyclic Nucleotide Phosphodiesterases, Type 3/*metabolism

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2007 Nov 15; Vol. 74 (10), pp. 1507-13. Date of Electronic Publication: 2007 Jul 26.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.

  • Authors : Ahlström M; Department of Applied Chemistry and Microbiology, University of Helsinki, P.O. Box 66, Helsinki 00014, Finland. ; Pekkinen M

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*metabolism ; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*enzymology ; Dexamethasone/Dexamethasone/Dexamethasone/*pharmacology

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2005 Jan 15; Vol. 69 (2), pp. 267-75. Date of Electronic Publication: 2004 Nov 06.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.

  • Authors : Ko WC; Graduate Institute of Pharmacology, College of Medicine, Taipei Medical University, Taipei, Taiwan. ; Shih CM

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; 3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/*antagonists & inhibitors ; Flavonoids/Flavonoids/Flavonoids/*pharmacology

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2004 Nov 15; Vol. 68 (10), pp. 2087-94.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells.

  • Authors : Kanda N; Department of Dermatology, Teikyo University, School of Medicine, 11-1, Kaga 2, Itabashi-Ku, Tokyo 173-8605, Japan. ; Watanabe S

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*metabolism ; Adenylyl Cyclases/Adenylyl Cyclases/Adenylyl Cyclases/*metabolism ; Interleukin-13/Interleukin-13/Interleukin-13/*metabolism

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2001 Aug 15; Vol. 62 (4), pp. 495-507.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

  • Authors : Sudo T; Thrombosis and Vascular Research Laboratory, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan. ; Tachibana K

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Isoenzymes/Isoenzymes/Isoenzymes/*antagonists & inhibitors ; Platelet Aggregation/Platelet Aggregation/Platelet Aggregation/*drug effects

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2000 Feb 15; Vol. 59 (4), pp. 347-56.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells.

  • Authors : Ashikaga T; Department of Pharmacology, University of South Alabama, College of Medicine, Mobile 36688, USA.; Strada SJ

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*metabolism ; 3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/*metabolism ; Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*enzymology

  • Source: Biochemical pharmacology [Biochem Pharmacol] 1997 Nov 15; Vol. 54 (10), pp. 1071-9.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.

  • Authors : Rowlands MG; Cancer Research Campaign Centre for Cancer Therapeutics, Institute of Cancer Research, CRC Laboratory, Belmont, Sutton, Surrey, U.K.; Grimshaw R

Subjects: Calmodulin/Calmodulin/Calmodulin/*metabolism ; Estrogen Antagonists/Estrogen Antagonists/Estrogen Antagonists/*pharmacology ; Receptors, Estrogen/Receptors, Estrogen/Receptors, Estrogen/*metabolism

  • Source: Biochemical pharmacology [Biochem Pharmacol] 1997 Jan 24; Vol. 53 (2), pp. 241-4.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Effects of KS-501, KS-502 and their enantiomers on calmodulin-sensitive enzyme activity and cellular proliferation.

  • Authors : Hait WN; Yale University School of Medicine, Department of Medicine, New Haven, CT 06510, USA.; Gesmonde J

Subjects: Calmodulin/Calmodulin/Calmodulin/*metabolism ; Cell Division/Cell Division/Cell Division/*drug effects ; Hydroxybenzoates/Hydroxybenzoates/Hydroxybenzoates/*pharmacology

  • Source: Biochemical pharmacology [Biochem Pharmacol] 1995 Jun 29; Vol. 50 (1), pp. 69-74.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues.

  • Authors : McCague R; Cancer Research Campaign Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, U.K.; Rowlands MG

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Calmodulin/Calmodulin/Calmodulin/*antagonists & inhibitors ; Receptors, Estrogen/Receptors, Estrogen/Receptors, Estrogen/*chemistry

  • Source: Biochemical pharmacology [Biochem Pharmacol] 1994 Oct 07; Vol. 48 (7), pp. 1355-61.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.

  • Authors : Wright CD; Department of Pharmacology, Parke-Davis Pharmaceutical Research, Warner-Lambert Co., Ann Arbor, MI 48105.; Kuipers PJ

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*physiology ; Neutrophils/Neutrophils/Neutrophils/*drug effects ; Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/*pharmacology

  • Source: Biochemical pharmacology [Biochem Pharmacol] 1990 Aug 15; Vol. 40 (4), pp. 699-707.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print Cited Medium: Print ISSN: 0006-2952 (Print)

Record details

Read More Add to Saved list
×
  • 1-10 of  16 results for ""Cyclic Nucleotide Phosphodiesterases, Type 1""